Delivery Order SPE2DB22D2211-SPE2DB24FMEC6
- Not listed
- This federal contract award is for the delivery of DURAMORPH 5 MG/10 ML AMPUL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,905.98 and is a Firm Fixed Price Delivery Order, with a performance period through July 9, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set-aside. Amerisourcebergen Drug Corp holds a large...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,094.67, is a delivery order for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML, a specialty pharmaceutical product. The award, valued at $1,130.00, has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order worth $2,042.55 for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of October 7, 2024 and is a Firm Fixed Price type. AmerisourceBergen is the prime contractor, and there is no set-aside designation for this award. The contract is associated with a larger Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of DURAMORPH 5 MG/10 ML AMPUL 10ML, a pharmaceutical product. The contract has a ceiling value of $1,973.24 and is a firm fixed-price delivery order type. There is no set-aside designation, indicating open competition. Amerisourcebergen Drug...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,649,492 units of the pharmaceutical product DURAMORPH 5 MG/10 ML AMPUL 10ML. The delivery order has a completion date of February 14, 2024 and a potential value of $3,385.23. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award, which does not have a...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) was issued by the Defense Logistics Agency (DLA) in the amount of $1,357.60. The award is for the delivery of DURAMORPH 10 MG/10 ML AMPUL 10ML, a pharmaceutical product, with a completion date of August 27, 2021. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,781.70 order is for DURAMORPH 5 MG/10 ML AMPUL 10ML, a specialty pharmaceutical product, with a completion date of February 29, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00, to...
- This is a federal delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The $1,122.08 firm-fixed-price contract is for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML, a medication. The contract has a period of performance through July 9, 2025 and is not set aside for any small business program. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract with DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,643.78, is for the delivery of DURAMORPH 10 MG/10 ML AMPUL 10ML, a pharmaceutical product. The contract has a firm-fixed price pricing type and a completion date of June 11, 2025. The award is not set-aside and represents open competition. AmerisourceBergen Drug Corp also holds a...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FMEC6Delivery Order
This contract award is for the delivery of DURAMORPH 5 MG/10 ML AMPUL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract has a ceiling value of $3,068.60 and is a firm fixed-price delivery order with a completion date of November 17, 2023. The contract was awarded on November 16, 2023, and there was no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 11/16/23 |